Literature DB >> 32302449

Covid-19: countermeasure for N95 mask-induced pressure sore.

Z Q Yin1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32302449      PMCID: PMC7264558          DOI: 10.1111/jdv.16490

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


× No keyword cloud information.
To the editor As known to all, World Health Organization has declared on March 11th, 2020 that Coronavirus (Covid‐19) epidemic could be characterized as a pandemic, which proposed a big challenge for healthcare works worldwide, especially doctors and nurses. The strong infectiousness of SARS‐CoV‐2 forces medical personnel to do good and needful safeguard against virus. The N95 Health Care Particulate Respirator and Surgical Mask (Fig. 1a) is the commonly used and effective protective equipment for preventing respiratory virus infection while working in isolation ward. However, in actual course of use, we found N95 mask would bring besetment to users, sometimes inevitably.
Figure 1

(a) N95 health care particulate respirator and surgical mask. (b) Pressure sore on nose bridge. (c) Application of benzalkonium chloride patch on nose bridge.

(a) N95 health care particulate respirator and surgical mask. (b) Pressure sore on nose bridge. (c) Application of benzalkonium chloride patch on nose bridge. The upward side of N95 mask has a metal strip on outer side and decompressing banding on inner side. The metal strip needs to be extruded to cling to nose bridge to reach good respiratory protection; however, pressure sore on nose bridge is liable to occur while working for long time, generally more than 4–6 h, although decompressing banding exists (Fig. 1b). The pressure sore could bring intense discomfort to user, and continuous working and wearing mask would further make sore more serious and even sick leave which would bring adverse impact on medical service system of various countries presently. Hydrocolloid dressing is often used to prevent and cure pressure sore, which is pasted to nose bridge before wearing mask, but we found the strong stickiness of dressing would likely aggravate existent pressure sore when taking off the mask and ripping away the dressing. If pressure sore does occur, the result of wearing N95 mask and using hydrocolloid dressing every day or other day would be from bad to worse. An improved method involving double protection that pasting benzalkonium chloride patch to the pressure sore on nose bridge firstly and using hydrocolloid dressing secondly before wearing mask (Fig. 1c). The high stickiness of both sides of benzalkonium chloride patch can keep the patch fastened to nose bridge, while the central part can protect the existent pressure sore due to decompressing effect and infection prevention and the low stickiness of central part would not make pressure sore more serious when ripping away the patch. However, above‐mentioned method is only an expedient measure, improving protective mask is a permanent solution. Although Covid‐19 will eventually be controlled and even eliminated worldwide, there are liable to face new epidemic situation in the future, and any improvement on protective equipment would be meaningful and benefit global health.

Acknowledgement

The patient in this manuscript has given written informed consent to publication of his case details.
  12 in total

1.  Cutaneous Manifestations of COVID-19: A Systematic Review.

Authors:  Harjas Singh; Harleen Kaur; Kanhaiya Singh; Chandan K Sen
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-10-19       Impact factor: 4.730

2.  Management of skin damage of health workers' face: the role of plastic surgery in the time of Pandemic.

Authors:  Roberto Cuomo; Francesco Ruben Giardino; Mirco Pozzi; Giuseppe Nisi; Andrea Sisti; Jingjian Han; Angelo Nuzzo; Alessia Muratori; Emanuele Cigna; Luigi Losco; Luca Grimaldi
Journal:  Acta Biomed       Date:  2021-05-12

3.  Experiences and Psychological Adjustments of Nurses Who Voluntarily Supported COVID-19 Patients in Hubei Province, China.

Authors:  Shasha Cui; Lei Zhang; Hongyan Yan; Qianyu Shi; Yujun Jiang; Qin Wang; Jing Chu
Journal:  Psychol Res Behav Manag       Date:  2020-12-03

4.  Taking care of healthcare workers during COVID-19 pandemic: does plastic surgery have a role?

Authors:  Francesco Ruben Giardino; Roberto Cuomo; Andrea Sisti; Jingjian Han; Nisi Giuseppe; Luca Grimaldi
Journal:  Acta Biomed       Date:  2020-11-10

5.  Skin Reactions to Personal Protective Equipment among First-Line COVID-19 Healthcare Workers: A Survey in Northern Morocco.

Authors:  Farah Marraha; Ibtissam Al Faker; Faiza Charif; Hanane Chahoub; Youness Benyamna; Najlaa Rahmani; Soukaina Kabbou; Yasmine Rkiek; Adil Najdi; Salim Gallouj
Journal:  Ann Work Expo Health       Date:  2021-10-09       Impact factor: 2.179

Review 6.  Does Wearing a Face Mask During the COVID-19 Pandemic Increase the Incidence of Dermatological Conditions in Health Care Workers? Narrative Literature Review.

Authors:  Robyn-Jenia Wilcha
Journal:  JMIR Dermatol       Date:  2021-05-06

Review 7.  Protective equipment-related pressure ulcers in healthcare workers during COVID-19 pandemic: A systematic review.

Authors:  Bilge Tezcan; Canan Eraydin; Bilgi Gülseven Karabacak
Journal:  J Tissue Viability       Date:  2022-02-19       Impact factor: 3.374

8.  Topical recombinant human acidic fibroblast growth factor: An effective therapeutic agent for facemask wearing-induced pressure sores.

Authors:  Pan Luo; Dong Liu; Juan Li
Journal:  Dermatol Ther       Date:  2020-07-01       Impact factor: 3.858

Review 9.  COVID-19 and dermatology: a comprehensive guide for dermatologists.

Authors:  D H Fahmy; H S El-Amawy; M A El-Samongy; A A Fouda; S H Soliman; A El-Kady; F Farnetani; A Conti; A Zoeir; A Eissa; R Eissa; S Puliatti; M C Sighinolfi; B Rocco; G Pellacani
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-06-10       Impact factor: 9.228

10.  Personal protective equipment induced facial dermatoses in healthcare workers managing Coronavirus disease 2019.

Authors:  M Singh; M Pawar; A Bothra; A Maheshwari; V Dubey; A Tiwari; A Kelati
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-06-02       Impact factor: 9.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.